MoneyWorks4Me

Zydus Lifesciences informs about press release

09 Sep 2022 Evaluate

Zydus Lifesciences has informed that it enclosed copy of press release dated September 9, 2022 titled ‘Zydus in-licenses a critical drug for CKD patients from Pharmacosmos A/S of Denmark’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..